Does adjuvant or neoadjuvant therapy improve prognosis of gastric cancer?;Magenkarzinom. Optimierung durch neoadjuvante und adjuvante Therapie?

Zentralblatt fur Chirurgie

Volumn 124, Issue 5, 1999, Pages 387-393

  Rosen, H ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b DANUBE HOSPITAL   (Austria)

Author keywords

Adjuvant therapy; Gastric cancer; Neoadjuvant therapy; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; PROGNOSIS; RELAPSE; STOMACH CANCER; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0033063187     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Agboola OL (1994) Adjuvant treatment in gastric cancer. Cancer Treat Rev 20: 217-240
2. Ajani JA, Ota DM, Jackson DE (1991) Current strategies in the management of locoregional and metastatic gastric carcinoma. Cancer 67: 260-265
3. Ajani JM, Ota DM, Jessup M, Ames FC, McBride C, Bodie A (1993) Preoperative and postoperative chemotherapy for patients with potentially resectable carcinoma. J Natl Cancer Inst 85: 1839-1843
4. Alcobendas F, Milla A, Estape J (1983) Mitomycin C as an adjuvant in resected gastric cancer. Ann Surg 198: 13-17
5. Allum WH, Hallissey MT, Ward LC (1989) A controlled, prospective randomized trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer. Interim report. British stomach group. Br J Cancer 60: 739-744
6. Alum WH, Hallissey MT, Kelly KA (1989) Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British stomach cancer group trial. Lancet I: 571-574
7. Atiqu O, Kelsen D, Shiu M (1991) Postoperative adjuvant intraperitoneal and intavenous chemotherapy in poor-risk gastric cancer patients. Proc Am Soc Clin Oncol 10: 137
8. Cady B, Ricardo L, Silverman, ML, Piccione W, Heck A (1989) Gastric adenocarcinoma. A disease in transition. Arch Surg 124: 303-308
9. Conroy TH, Wils J, Wagener DJTH (1992) International Conference on Biology and Treatment of Gastrointestinal Malignancies. Abstract. p 72
10. Coombes RC, Schein PS, Chilvers CE (1990) A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer. ICCG. J Clin Oncol 8: 1362-1369
11. Crookes P, Leichmann CG, Leichman L, Tan M, Laine L, Stain S, Baranda J, Casagrande Y, Groshen S, Silberman H (1997) Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy. Cancer 79: 1767-1775
12. Douglas HO, Stablein DM, Bruckner HM (1982) Controlled trial of adjuvant chemotherapy folowing curative resection for gastric cancer: the gastrointestinal tumor study group. Cancer 49: 1116-1122
13. Engstrom PF, Lavin PT, Douglass HO (1985) Postoperative adjuvant 5-FU plus MeCNNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275). Cancer 55: 1868-1873
14. Fink U, Schuhmacher C, Stein HJ, Busch R, Feussner H, Dittler HJ, Helmberger A, Böttcher K, Siewert JR (1995) Preoperative chemotherapy for stage II-IV gastric carcinoma, response and outcome after complete resection. Br J Surg 82: 1248-1252
15. Fisher B, Gunduz N, Coyle J (1989) Presence of a growth stimulating factor in serum following primary tumor removal in mice. Cancer Res 49: 1996-2001
16. Goldie JH, Coldman AJ (1979) A mathematical model for relating drug sensitivity of tumors and their spontaneous mutation rate. Cancer Treat Rep 63: 1727-1733
17. Gunderson LL, Sosin H (1982) Adenocarcinom of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8: 1-11
18. Hagiwara A, Takahashi T, Kojima O (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339: 629-631
19. Hamazoe R, Maeta M, Kaibara N (1994) Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 73: 2048-2052
20. Hermans J, Bonenkamp JJ, Boon MC, Blunt AMG, Ohyama M, Sasako M, Van de Velde CJH (1993) Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomised trials. J Clin Oncol 11: 1441-1447
21. Higgins GA, Amadeo JH, Smith DE (1983) Efficacy of prolonged intermittent therapy with 5-FU and methy.CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report. Cancer 52: 1005-1012
22. Jakesz R, Dittrich C, Funovics J (1988) The effect of adjuvant chemotherapy in gastric carcinoma is dependent to tumor histology, 5-years results of a prospective randomized trial. Rec Results Cancer Res 110: 44-51
23. Kelsen DA, Atiqu OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale CH, Vinciguerra VI, Brennan MU (1992) FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 10: 541-548
24. Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M (1996) Neoadjuvant therapy of high-risk gastric cancera phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14: 1818-1828
25. Krook JE, O'Connel R, Wieand HS (1991) A prospective randomized evaluation of intensive course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer 67: 2454-2458
26. Lasser PH, Rougier PH, Mahajoubi M (1991) Neoadjuvant chemotherapy (NCT) in locally advanced gastric cancer (LAGC) (abstract ECCO-6). Eur J Cancer [Suppl] 2: 71
27. Leichman L, Silverman H, Leichman G, Spears CP, Ray M, Muggia FM, Kiyabu M, Laine L, Stain S, Fuerst K, Groshen S, Donovan A (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer. J Clin Oncol 12: 1933-1942
28. Lerner A, Gonin R, Steel GD, Mayer AJ (1992) Etoposide, doxorubicin and cisplatin chemotherapy for advanced gastric carcinoma a phase II trial. J Clin Oncol 10: 536-540
29. Macdonald J, Schein P, Wooley P (1980) 5-Fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93: 533-536
30. McNeer G, Vanderberg H, Donn F (1951) A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 134: 1-7
31. Melcher AA, Mort D, Maughan TS (1996) Epirubicin, cisplatin and continous infusion 5-fluorouracil (ECF) as neoadjuvant chemtoherapy in gastro-oesophageal cancer. Br J Cancer 74: 1651-1654
32. Plukker JTH, Mulder NH, Yerschueren RCJ (1989) Combined chemotherapeutic/ surgical approach of locally advanced gastric cancer of the cardiac and gastric fundus. Abstracts of EORTC Symposium on Advances in Gastrointestinal Tract Cancer Research and Treatment. Leyden, p 41
33. Roder JD, Böttcher K, Siewert JR (1993) Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 72: 2089-2097
34. Rosen HR, Scheithauer W, Jakesz R, Böhmig HJ, Schennach W, Depisch D, Hausmaninger H, Stierer M, Sebesta C, Schiessel R (1995) Epirubicin, etoposide and cisplatin in the treatment of locally advanced nonresectable gastric carcinoma. Results of a multicentric pilot study. GI Cancer 1: 49-53
35. Rougier PH, Lasser PH, Ducreux M, Mahjoubi M, Bongel C, Elias D (1994) Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5 [Suppl]: 59-68
36. Sautner T, Hofbauer F, Depisch D (1994) Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 12: 970-974
37. Schiessel R, Funovics J, Schick B (1989) Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomised trial. Acta Medica Austriaca 16: 68-69
38. Sugarbaker PH, Cunliffe WJ, Belliveau J (1989) Rationale for integrating early postoperative intraperitoneal chemotherpy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16: 83-97
39. Wilke HJ, Preusser P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Geerlings H, Köhne-Wömper CH, Harstrick A, Schmoll HJ (1990) New developments in the treatment of gastric carcinoma. Semin Oncol 17 [Suppl] 2: 61-70
40. Wils J, Klein HO, Wagener DJTH (1991) Sequential high dose methotrexate and 5-fluorouracil combined with doxorubicin: a step ahead in the treatment of advanced gastric cancer. A trial of the EORTC gastro-intestinal (GI) tract cooperative group. J Clin Oncol 9: 827-831